Cargando…

Induction of retinopathy by fibrillar oxalate assemblies

The formation of metabolite fibrillar assemblies represents a paradigm shift in the study of human metabolic disorders. Yet, direct clinical relevance has been attributed only to metabolite crystals. A notable example for metabolite crystallization is calcium oxalate crystals observed in various dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaguri, Dor, Shaham-Niv, Shira, Naaman, Efrat, Mimouni, Michael, Magen, Daniella, Pollack, Shirley, Kreiser, Topaz, Leibu, Rina, Rencus-Lazar, Sigal, Adler-Abramovich, Lihi, Perlman, Ido, Gazit, Ehud, Zayit-Soudry, Shiri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812261/
https://www.ncbi.nlm.nih.gov/pubmed/36703385
http://dx.doi.org/10.1038/s42004-019-0247-8
_version_ 1784863690734960640
author Zaguri, Dor
Shaham-Niv, Shira
Naaman, Efrat
Mimouni, Michael
Magen, Daniella
Pollack, Shirley
Kreiser, Topaz
Leibu, Rina
Rencus-Lazar, Sigal
Adler-Abramovich, Lihi
Perlman, Ido
Gazit, Ehud
Zayit-Soudry, Shiri
author_facet Zaguri, Dor
Shaham-Niv, Shira
Naaman, Efrat
Mimouni, Michael
Magen, Daniella
Pollack, Shirley
Kreiser, Topaz
Leibu, Rina
Rencus-Lazar, Sigal
Adler-Abramovich, Lihi
Perlman, Ido
Gazit, Ehud
Zayit-Soudry, Shiri
author_sort Zaguri, Dor
collection PubMed
description The formation of metabolite fibrillar assemblies represents a paradigm shift in the study of human metabolic disorders. Yet, direct clinical relevance has been attributed only to metabolite crystals. A notable example for metabolite crystallization is calcium oxalate crystals observed in various diseases, including primary hyperoxaluria. We unexpectedly observed retinal damage among young hyperoxaluria patients in the absence of crystals. Exploring the possible formation of alternative supramolecular organizations and their biological role, here we show that oxalate can form ordered fibrils with no associated calcium. These fibrils inflict intense retinal cytotoxicity in cultured cells. A rat model injected with oxalate fibrils recaptures patterns of retinal dysfunction observed in patients. Antibodies purified from hyperoxaluria patient sera recognize oxalate fibrils regardless of the presence of calcium. These findings highlight a new molecular basis for oxalate-associated disease, and to our knowledge provide the first direct clinical indication for the pathogenic role of metabolite fibrillar assemblies.
format Online
Article
Text
id pubmed-9812261
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-98122612023-01-10 Induction of retinopathy by fibrillar oxalate assemblies Zaguri, Dor Shaham-Niv, Shira Naaman, Efrat Mimouni, Michael Magen, Daniella Pollack, Shirley Kreiser, Topaz Leibu, Rina Rencus-Lazar, Sigal Adler-Abramovich, Lihi Perlman, Ido Gazit, Ehud Zayit-Soudry, Shiri Commun Chem Article The formation of metabolite fibrillar assemblies represents a paradigm shift in the study of human metabolic disorders. Yet, direct clinical relevance has been attributed only to metabolite crystals. A notable example for metabolite crystallization is calcium oxalate crystals observed in various diseases, including primary hyperoxaluria. We unexpectedly observed retinal damage among young hyperoxaluria patients in the absence of crystals. Exploring the possible formation of alternative supramolecular organizations and their biological role, here we show that oxalate can form ordered fibrils with no associated calcium. These fibrils inflict intense retinal cytotoxicity in cultured cells. A rat model injected with oxalate fibrils recaptures patterns of retinal dysfunction observed in patients. Antibodies purified from hyperoxaluria patient sera recognize oxalate fibrils regardless of the presence of calcium. These findings highlight a new molecular basis for oxalate-associated disease, and to our knowledge provide the first direct clinical indication for the pathogenic role of metabolite fibrillar assemblies. Nature Publishing Group UK 2020-01-03 /pmc/articles/PMC9812261/ /pubmed/36703385 http://dx.doi.org/10.1038/s42004-019-0247-8 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Zaguri, Dor
Shaham-Niv, Shira
Naaman, Efrat
Mimouni, Michael
Magen, Daniella
Pollack, Shirley
Kreiser, Topaz
Leibu, Rina
Rencus-Lazar, Sigal
Adler-Abramovich, Lihi
Perlman, Ido
Gazit, Ehud
Zayit-Soudry, Shiri
Induction of retinopathy by fibrillar oxalate assemblies
title Induction of retinopathy by fibrillar oxalate assemblies
title_full Induction of retinopathy by fibrillar oxalate assemblies
title_fullStr Induction of retinopathy by fibrillar oxalate assemblies
title_full_unstemmed Induction of retinopathy by fibrillar oxalate assemblies
title_short Induction of retinopathy by fibrillar oxalate assemblies
title_sort induction of retinopathy by fibrillar oxalate assemblies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812261/
https://www.ncbi.nlm.nih.gov/pubmed/36703385
http://dx.doi.org/10.1038/s42004-019-0247-8
work_keys_str_mv AT zaguridor inductionofretinopathybyfibrillaroxalateassemblies
AT shahamnivshira inductionofretinopathybyfibrillaroxalateassemblies
AT naamanefrat inductionofretinopathybyfibrillaroxalateassemblies
AT mimounimichael inductionofretinopathybyfibrillaroxalateassemblies
AT magendaniella inductionofretinopathybyfibrillaroxalateassemblies
AT pollackshirley inductionofretinopathybyfibrillaroxalateassemblies
AT kreisertopaz inductionofretinopathybyfibrillaroxalateassemblies
AT leiburina inductionofretinopathybyfibrillaroxalateassemblies
AT rencuslazarsigal inductionofretinopathybyfibrillaroxalateassemblies
AT adlerabramovichlihi inductionofretinopathybyfibrillaroxalateassemblies
AT perlmanido inductionofretinopathybyfibrillaroxalateassemblies
AT gazitehud inductionofretinopathybyfibrillaroxalateassemblies
AT zayitsoudryshiri inductionofretinopathybyfibrillaroxalateassemblies